The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guerin failures for non-muscle-invasive bladder cancer
Conclusion:
Based on analysis of available published data, MCNA offers a durable response for a small proportion of patients that have failed prior intravesical therapy. There still exists a large unmet need for nonsurgical treatment options for patients with NMIBC who have failed adjuvant intravesical therapies.
Source: Therapeutic Advances in Urology - Category: Urology & Nephrology Authors: Packiam, V. T., Pearce, S. M., Steinberg, G. D. Tags: Reviews Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | Immunotherapy | Study | Urology & Nephrology